XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities          
Net increase (decrease) in net assets resulting from operations $ 160 $ 265 $ 438 $ 606  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Purchases of investments     (3,840) (1,137)  
Paid-in-kind interest     (107) (116)  
Proceeds from sales and repayments of investments     4,512 1,906  
Net realized (gain) loss on investments     350 338  
Net change in unrealized (appreciation) depreciation on investments     (160) (237)  
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts     19 3  
Accretion of discount     (49) (43)  
Amortization of deferred financing costs and discount     14 12  
Unrealized (gain)/loss on borrowings in foreign currency     13 (11)  
(Increase) decrease in receivable for investments sold and repaid     (222) 36  
(Increase) decrease in income receivable     (23) (90)  
(Increase) decrease in prepaid expenses and other assets     (19) 6  
Increase (decrease) in payable for investments purchased     1 (14)  
Increase (decrease) in management fees payable     (2) (3)  
Increase (decrease) in subordinated income incentive fees payable     3 20  
Increase (decrease) in administrative services expense payable     0 0  
Increase (decrease) in interest payable     1 (11)  
Increase (decrease) in other accrued expenses and liabilities     (24) (15)  
Mark-to-market of hedged debt     18 0  
Net cash provided by (used in) operating activities     923 1,250  
Cash flows from financing activities          
Repurchases of common stock     0 (32)  
Stockholder distributions     (616) (612)  
Borrowings under financing arrangements     3,425 1,127  
Repayments of financing arrangements     (3,577) (1,801)  
Deferred financing costs paid     (15) (7)  
Net cash provided by (used in) financing activities     (783) (1,325)  
Total increase (decrease) in cash     140 (75)  
Cash, cash equivalents and foreign currency at beginning of period     231 251 $ 251
Cash, cash equivalents and foreign currency at end of period $ 371 $ 176 371 176 $ 231
Supplemental disclosure          
Non-cash purchases of investments     (1,055) (89)  
Non-cash sales of investments     1,055 89  
Local and excise taxes paid     26 20  
Interest paid during the period     $ 334 $ 348